Contact Sales
.
banner
Whitepaper
Whitepaper

Best Practices for Complying with 340B

Fill out the form to download this whitepaper

The Public Health Service Act 340B Drug Pricing Program enables providers that serve vulnerable patient populations to access outpatient drugs at significantly lower costs, which helps improve overall patient care. But for pharmaceutical manufacturers, program management can be extremely challenging.

Changes to the 340B program have led to an increase in the number of covered entities and contract pharmacies, as well as more stringent financial and legal implications for price errors.

For pharmaceutical manufacturers that participate in the 340B program, effective management of pricing, rebates, and chargebacks is crucial to protecting revenue streams and ensuring compliance. In this white paper, you’ll learn how you can improve your chargeback process, generate an audit trail, and ensure correct 340B pricing.

In this white paper we will:

  • Discuss important changes to the 340B Drug Pricing Program.
  • Provide best practices and practical approaches for streamlining 340B program management.
  • Explain how you can reduce the risk of revenue leakage and noncompliance.

Some of our customers:

astrazeneca-logo
abbvie logo
dr._reddys_laboratories_logo
johnson_and_johnson_logo
gilead_logo

You might also be interested in

fierce-pharma
webinar
webinar
webinar
Preparing for Commercialization While You’re in Development
Learn how to position yourself in the market with innovative launch strategies and relationship building. VIEW webinar
novartis-case-study
case studies
case studies
case-studies
Novartis and Model N: Partners in Revenue Management
Novartis has been a user of Model N’s revenue cloud for life sciences for over 15 years, as one of Model N’s founding clients. Over the years, Novartis has leveraged the Model N platform to automate pricing... VIEW case-studies
innovative-commercial-contracts
whitepaper
whitepaper
whitepaper
Maximize the Value of Innovative Commercial Contracts
Innovative contracting approaches are growing in popularity with pharmaceutical companies. They drive demand and sales, but they also come with potential pitfalls that can impact your company’s success. VIEW whitepaper
.

Start typing and press Enter to search